article thumbnail

Every Day Counts for PTE: Court Finds FDA’s Reinterpretation of Testing Phase Arbitrary and Capricious

FDA Law Blog

Patent and Trademark Office consulted with FDA on the appropriate timelines, FDA claimed that the INAD, and thereby the testing phase, was not effective until August 4, 2011 because no NCIE was submitted until then. Thus, the Agency concluded, the June 2011 date should stand. When the U.S.

article thumbnail

Using technology to reclaim our time

Today's Hospitalist

Looking ahead, here are several emerging innovations that promise to shape the next generation of these tools: Deeper integration with hospitalist workflow: Initiating an AI-assisted note may soon be as effortless as speaking naturally during a patient consult—no disruptions, no clicks. References: 1. Shanafelt TD, West CP, Sinsky C, et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

OTAT Town Hall on Cell Therapy CMC – The Recording is Available but Here’s an Appetizer

FDA Law Blog

The Agency referred to its 2011 FDA Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products during the town hall. Per the 2011 FDA Guidance, developers should validate the assay prior to conducting a clinical study that will investigate the efficacy for licensure. Comparability.

article thumbnail

No Sleep ‘Til District Court: Jazz Sues FDA Over Sodium Oxybate Clinical Superiority Determination

FDA Law Blog

The record also does not reflect consultation with the requisite experts, and FDA ignored some of the risks associated with elevated sodium intake, which is precisely the benefit provided by Xywav. Jazz believes that FDA precedent precludes that position and thus FDA departed from established policy, which FDA denied ever existed.

Clinic 52
article thumbnail

Storycatching: Podcast with Heather Coats and Thor Ringler

GeriPal

Eric’s blog post on Dignity Therapy from 2011. So those questions we ask when we’re doing a palliative care consult. Or volunteers, we have volunteers on our palliative care team that are doing story catching, not in my research project because I don’t have persons who are receiving formal palliative care consults.

article thumbnail

Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky

GeriPal

So those questions we ask when we’re doing a palliative care consult. Or volunteers, we have volunteers on our palliative care team that are doing story catching, not in my research project because I don’t have persons who are receiving formal palliative care consults. We need to remedy that issue, Eric.

IT 105
article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

Eric 13:00 I also love that too, because even on our inpatient ballot of care consult service, whenever somebody says that they’re unrepresented or they don’t have a surrogate, we never believe that until we usually look up. You know, baby boomer generation started to turn 65 and older back in 2011.